Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Draper

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Frontiers in Molecular Neuroscience|August 24, 2023
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's diseaseKaitlin Flannagan, Julia A Stopperan, Brittany M Hauger, et al.
Science Advances|April 9, 2025
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responsesKilyna A Nguyen, Zhihui Liu, John S Davies, et al.
Microbiology Resource Announcements|October 13, 2022
Draft Genome Sequences for 6 Isolates of Endospore-Forming Class <i>Bacilli</i> Species Isolated from Soil from a Suburban, Wooded, Developed SpaceAnna L McLoon, Thomas T Awad, Molly F Bogardus, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Activation-dependent lentiviruses enable antigen-specific T cell expansion and transductionBlake E Smith, Lindsey M Draper, Andrea Garmilla, et al.
Cell Reports|May 24, 2016
IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISCHanane Ennajdaoui, Jonathan M Howard, Timothy Sterne-Weiler, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|October 2, 2025
Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumorsKyle B Williams, Alex T Larsson, Bryant J Keller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2015
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cellsSanja Stevanović, Lindsey M Draper, Michelle M Langhan, et al.
Frontiers in Molecular Neuroscience|August 24, 2023
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's diseaseKaitlin Flannagan, Julia A Stopperan, Brittany M Hauger, et al.
Science Advances|April 9, 2025
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responsesKilyna A Nguyen, Zhihui Liu, John S Davies, et al.
Microbiology Resource Announcements|October 13, 2022
Draft Genome Sequences for 6 Isolates of Endospore-Forming Class <i>Bacilli</i> Species Isolated from Soil from a Suburban, Wooded, Developed SpaceAnna L McLoon, Thomas T Awad, Molly F Bogardus, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Activation-dependent lentiviruses enable antigen-specific T cell expansion and transductionBlake E Smith, Lindsey M Draper, Andrea Garmilla, et al.
Cell Reports|May 24, 2016
IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISCHanane Ennajdaoui, Jonathan M Howard, Timothy Sterne-Weiler, et al.
Pageof 14